---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-061837"
form_type: "8-K"
ticker: "LONA"
cik: "0001620463"
company_name: "LeonaBio, Inc."
filed_at: "2024-05-17T23:59:59+00:00"
generated_at: "2026-06-01T15:59:19.761994+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Athira Pharma obtains preliminary approval for derivative lawsuit settlement with governance reforms

## Summary
- Court preliminary approval on May 3, 2024; final hearing set for July 18, 2024.
- Settlement requires Athira to adopt corporate governance reforms and pay lead plaintiffs' attorney's fees, expenses, and service awards.
- Derivative actions Bushansky v. Kawas and Houlihan v. Kawas covered by the Stipulation of Settlement dated March 15, 2024.

## SEC filing metadata
- accession: 0000950170-24-061837
- form_type: 8-K
- ticker: LONA
- cik: 0001620463
- company_name: LeonaBio, Inc.
- filed_at: 2024-05-17T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1620463/000095017024061837/0000950170-24-061837-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1620463/000095017024061837/atha-20240503.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-061837
- JSON: https://secwatch.observer/filing/0000950170-24-061837.json
- Plain text: https://secwatch.observer/filing/0000950170-24-061837.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.